l-carnitine tmao koeth 2013 nature medicine TMAO: how gut microbiota contributes to heart failure Gut Microbiota-Dependent Marker TMAO in
Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO ScienceDirect Trimethylamine N Oxide in Relation to Cardiometabolic HealthCause or Effect? Trimethylamine N Oxide From Gut Microbiota in Chronic Kidney Disease Patients: Focus on Diet Journal of Renal Nutrition Frontiers Impacts of intestinal microbiota metabolite trimethylamine N oxide on cardiovascular disease: a bibliometric analysis Meat metabolizing bacteria in atherosclerosis Nature Medicine
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9





